NOFSA statement on generic bisphosphonates.
Hough
Stephen
S
D019386:Alendronate / Q000493:pharmacokinetics* / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control*; D012955:Societies, Medical; D013019:South Africa; D013810:Therapeutic Equivalency
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate